Page last updated: 2024-12-11

(10)-shogaol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

**(10)-Shogaol** is a bioactive compound found in ginger (Zingiber officinale). It is a pungent, spicy compound that is responsible for some of the medicinal properties of ginger.

Here's why (10)-shogaol is important for research:

**1. Potential Health Benefits:**

* **Anti-inflammatory:** (10)-shogaol has been shown to exhibit potent anti-inflammatory activity. It can inhibit the production of inflammatory mediators, such as prostaglandins and cytokines. This makes it a potential therapeutic agent for conditions like arthritis, inflammatory bowel disease, and asthma.
* **Antioxidant:** (10)-shogaol acts as an antioxidant, protecting cells from damage caused by free radicals. This may contribute to its anti-cancer, anti-aging, and neuroprotective properties.
* **Antiemetic:** (10)-shogaol is believed to help alleviate nausea and vomiting, particularly in cases of motion sickness and chemotherapy-induced nausea.
* **Analgesic:** Some studies suggest that (10)-shogaol may possess pain-relieving effects.

**2. Research Focus:**

* **Cancer:** Researchers are exploring the potential of (10)-shogaol as a cancer-fighting agent. Studies have indicated that it may inhibit the growth and spread of certain cancer cells.
* **Neurological Disorders:** (10)-shogaol is being investigated for its potential role in treating neurological conditions like Alzheimer's disease, Parkinson's disease, and stroke. It may protect brain cells from damage and improve cognitive function.
* **Cardiovascular Health:** Research is ongoing to examine the effects of (10)-shogaol on heart health. It may help lower blood pressure, improve cholesterol levels, and reduce the risk of cardiovascular disease.

**3. Pharmacological Properties:**

* **Bioavailability:** (10)-shogaol is generally well absorbed and has a good bioavailability in humans.
* **Stability:** It is relatively stable at room temperature, making it suitable for use in various formulations.

**4. Advantages over Gingerol:**

* (10)-shogaol is a more stable and potent form of gingerol, the main active compound in fresh ginger.
* It has a longer half-life than gingerol, meaning it stays in the body for a longer duration.

**Current Research:**

Currently, research on (10)-shogaol is ongoing to investigate its potential therapeutic applications and to further understand its mechanisms of action. Scientists are developing new ways to extract and formulate (10)-shogaol for use in dietary supplements, pharmaceuticals, and food products.

**Conclusion:**

(10)-shogaol is a promising bioactive compound with potential therapeutic benefits for various health conditions. Further research is needed to fully understand its properties and to develop effective applications for human health.

(10)-shogaol: isolated from ginger; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6442612
CHEMBL ID24226
CHEBI ID192883
SCHEMBL ID4885150
SCHEMBL ID4885163
MeSH IDM0589809

Synonyms (41)

Synonym
MEGXP0_001221
ACON1_001059
NCGC00169717-01
(e)-1-(4-hydroxy-3-methoxy-phenyl)tetradec-4-en-3-one
CHEMBL24226 ,
10-shogaol
BRD-K70733829-001-01-3
(e)-1-(4-hydroxy-3-methoxy-phenyl)-tetradec-4-en-3-one
bdbm50317423
36752-54-2
[10]-shogaol
(e)-1-(4-hydroxy-3-methoxyphenyl)tetradec-4-en-3-one
CHEBI:192883
4-tetradecen-3-one, 1-(4-hydroxy-3-methoxyphenyl)-, (4e)-
104186-05-2
SCHEMBL4885150
SCHEMBL4885163
FADFGCOCHHNRHF-VAWYXSNFSA-N
1-(4-hydroxy-3-methoxyphenyl)tetradec-4-en-3-one
unii-up39bhe708
AC-34350
trans-(10)-shogaol
UP39BHE708 ,
4-tetradecen-3-one, 1-(4-hydroxy-3-methoxyphenyl)-
(10)-shogaol
10-shogaol (constituent of ginger) [dsc]
(e)-(10)-shogaol
(4e)-1-(4-hydroxy-3-methoxyphenyl)tetradec-4-en-3-one
AKOS030530375
1-(4-hydroxy-3-methoxyphenyl)-4-tetradecen-3-one
mfcd00916692
ncgc00169717-02!(e)-1-(4-hydroxy-3-methoxyphenyl)tetradec-4-en-3-one
DTXSID40873730 ,
ZB1863
HY-N2434
CS-0022652
Q27291178
MS-25013
(e)-1-(4-hydroxy-3-methoxyphenyl) tetradec-4-ene-3-one
dtxcid101011954
10-shogaol (constituent of ginger)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (3)

ClassDescription
monomethoxybenzeneCompounds containing a benzene skeleton substituted with one methoxy group.
phenolsOrganic aromatic compounds having one or more hydroxy groups attached to a benzene or other arene ring.
enoneAn alpha,beta-unsaturated ketone of general formula R(1)R(2)C=CR(3)-C(=O)R(4) (R(4) =/= H) in which the C=O function is conjugated to a C=C double bond at the alpha,beta position.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
5-hydroxytryptamine receptor 1AHomo sapiens (human)Ki5.84000.00010.532610.0000AID480937
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (15)

Processvia Protein(s)Taxonomy
behavioral fear response5-hydroxytryptamine receptor 1AHomo sapiens (human)
G protein-coupled receptor signaling pathway5-hydroxytryptamine receptor 1AHomo sapiens (human)
adenylate cyclase-inhibiting serotonin receptor signaling pathway5-hydroxytryptamine receptor 1AHomo sapiens (human)
serotonin receptor signaling pathway5-hydroxytryptamine receptor 1AHomo sapiens (human)
gamma-aminobutyric acid signaling pathway5-hydroxytryptamine receptor 1AHomo sapiens (human)
positive regulation of cell population proliferation5-hydroxytryptamine receptor 1AHomo sapiens (human)
regulation of serotonin secretion5-hydroxytryptamine receptor 1AHomo sapiens (human)
regulation of vasoconstriction5-hydroxytryptamine receptor 1AHomo sapiens (human)
exploration behavior5-hydroxytryptamine receptor 1AHomo sapiens (human)
regulation of dopamine metabolic process5-hydroxytryptamine receptor 1AHomo sapiens (human)
serotonin metabolic process5-hydroxytryptamine receptor 1AHomo sapiens (human)
regulation of hormone secretion5-hydroxytryptamine receptor 1AHomo sapiens (human)
regulation of behavior5-hydroxytryptamine receptor 1AHomo sapiens (human)
chemical synaptic transmission5-hydroxytryptamine receptor 1AHomo sapiens (human)
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger5-hydroxytryptamine receptor 1AHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (5)

Processvia Protein(s)Taxonomy
G protein-coupled serotonin receptor activity5-hydroxytryptamine receptor 1AHomo sapiens (human)
protein binding5-hydroxytryptamine receptor 1AHomo sapiens (human)
receptor-receptor interaction5-hydroxytryptamine receptor 1AHomo sapiens (human)
neurotransmitter receptor activity5-hydroxytryptamine receptor 1AHomo sapiens (human)
serotonin binding5-hydroxytryptamine receptor 1AHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (3)

Processvia Protein(s)Taxonomy
plasma membrane5-hydroxytryptamine receptor 1AHomo sapiens (human)
synapse5-hydroxytryptamine receptor 1AHomo sapiens (human)
plasma membrane5-hydroxytryptamine receptor 1AHomo sapiens (human)
dendrite5-hydroxytryptamine receptor 1AHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (12)

Assay IDTitleYearJournalArticle
AID480941Antagonist activity at 5HT1A receptor expressed in HEK293 cells assessed as inhibition of 8-OH-DPAT-induced [S35]GTPgammaS binding by scintillation counting2010Bioorganic & medicinal chemistry, May-01, Volume: 18, Issue:9
Identification of serotonin 5-HT1A receptor partial agonists in ginger.
AID480936Cytotoxicity against human Caco-2 cells at 50 ug/ml2010Bioorganic & medicinal chemistry, May-01, Volume: 18, Issue:9
Identification of serotonin 5-HT1A receptor partial agonists in ginger.
AID1439509Antihelmintic activity against Hymenolepis nana2017European journal of medicinal chemistry, Mar-31, Volume: 129Medicinal plants used as anthelmintics: Ethnomedical, pharmacological, and phytochemical studies.
AID480938Displacement of [3H]8-OH-DPAT from 5HT1A receptor expressed in HEK293 cells at 25 ug/ml after 2 hrs by liquid scintillation counting2010Bioorganic & medicinal chemistry, May-01, Volume: 18, Issue:9
Identification of serotonin 5-HT1A receptor partial agonists in ginger.
AID156507Effective dose to protect PC12 cells from beta-Amyloid (BA) insult was determined using MTT reduction assay2004Bioorganic & medicinal chemistry letters, Mar-08, Volume: 14, Issue:5
Side-chain length is important for shogaols in protecting neuronal cells from beta-amyloid insult.
AID480939Agonist activity at 5HT1A receptor expressed in HEK293 cells by [S35]GTPgammaS binding assay relative to 8-OH-DPAT2010Bioorganic & medicinal chemistry, May-01, Volume: 18, Issue:9
Identification of serotonin 5-HT1A receptor partial agonists in ginger.
AID480943Permeability in human Caco-2 cells assessed as passive diffusion after 3 hrs by HPLC2010Bioorganic & medicinal chemistry, May-01, Volume: 18, Issue:9
Identification of serotonin 5-HT1A receptor partial agonists in ginger.
AID91529Effective dose to protect IMR-32 cells from beta-Amyloid (BA) insult was determined using MTT reduction assay2004Bioorganic & medicinal chemistry letters, Mar-08, Volume: 14, Issue:5
Side-chain length is important for shogaols in protecting neuronal cells from beta-amyloid insult.
AID480937Displacement of [3H]8-OH-DPAT from 5HT1A receptor expressed in HEK293 cells after 2 hrs by liquid scintillation counting2010Bioorganic & medicinal chemistry, May-01, Volume: 18, Issue:9
Identification of serotonin 5-HT1A receptor partial agonists in ginger.
AID480940Agonist activity at 5HT1A receptor expressed in HEK293 cells at >20 uM by [S35]GTPgammaS binding assay relative to 8-OH-DPAT2010Bioorganic & medicinal chemistry, May-01, Volume: 18, Issue:9
Identification of serotonin 5-HT1A receptor partial agonists in ginger.
AID480944Inhibition of human MDR1 expressed in MDCK cells assessed as fluorescence activity at 30 uM after 1.5 hrs by rhodamine 123 efflux test2010Bioorganic & medicinal chemistry, May-01, Volume: 18, Issue:9
Identification of serotonin 5-HT1A receptor partial agonists in ginger.
AID480942Antagonist activity at 5HT1A receptor expressed in HEK293 cells assessed as inhibition of serotonin-induced [S35]GTPgammaS binding by scintillation counting2010Bioorganic & medicinal chemistry, May-01, Volume: 18, Issue:9
Identification of serotonin 5-HT1A receptor partial agonists in ginger.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's5 (83.33)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 22.09

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index22.09 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.73 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (22.09)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (16.67%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (83.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]